What is Epithalon? It is a synthetic tetrapeptide, four amino acids in sequence, written as Ala-Glu-Asp-Gly and also spelled Epitalon. It is sold on claims about telomerase and life extension. It holds no marketing authorisation anywhere in the world, and no study in any organism has measured muscle mass, strength or body fat after giving it.
The vendor we point lifters to
Epithalon from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The certificate for batch 15-05260628 assays this vial at 9.64 mg against a 10 mg label, inside the stated 10 percent tolerance, which puts the real figure at $2.59/mg on that batch. It carries purity, identity, endotoxin, sterility and heavy metals. Buying 3, 5 or 10 takes 3%, 5% or 10% off list.
- Endotoxin, sterility and heavy metals on the batch certificate
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified September 8, 2026.
The interesting part of the answer is not the molecule. It is where the evidence about it comes from, which is a narrower place than most articles admit.
What is Epithalon, stated without the anti ageing framing
The peptide was derived from Epithalamin, a preparation made from the pineal gland. That lineage explains everything about how the compound is marketed. The pineal gland is associated with circadian regulation and with ageing research, so a peptide drawn from a pineal preparation arrives already wrapped in the language of biological time.
The synthetic tetrapeptide was made as a defined, reproducible substitute for the extract. That is a normal and sensible move in pharmacology: an extract is a mixture, and a mixture is hard to standardise, dose or study.
What did not follow was the rest of the normal path. There is no marketing authorisation from any regulator, in any country, for any indication. There are no registered interventional trials on the main Western trial registry. Outside the research setting it is sold as a research chemical, which is a legal category rather than a description of quality.
One research group, and what that does to a finding
This is the fact that should shape how a reader treats everything else on the page.
The literature on this peptide comes largely from a single research group, Khavinson and colleagues in St Petersburg, working on pineal peptides over an extended programme. The telomerase claims and the lifespan claims trace back to that body of work. Independent replication outside that group is limited.
That is not an accusation. Concentrated literatures are common for compounds developed inside one institute, and they are how many drugs begin. It is a statement about what the evidence can currently support.
Replication is the mechanism by which science removes the effects of a single laboratory's methods, assumptions and expectations. A result confirmed by an unrelated group in a different country using different reagents has survived a test that an unreplicated result has not faced. The two are different kinds of claim, and a reader is entitled to know which kind they are being offered.
So the correct phrasing for almost every impressive statement about this compound is attributive. That group reported it. Not: it has been shown.
The two claims that do the selling
Telomerase activation is the first. Telomerase is an enzyme that extends telomeres, the repeated sequences at chromosome ends that shorten as cells divide. Work from the group above reported telomerase related effects in human cell culture. Cell culture is the organism here, and that word matters: a cultured cell line dividing in a dish is a long way from a person.
Lifespan extension is the second. Work from the same programme in mice and rats reported effects on lifespan. Those results have not been independently replicated at scale outside that group, and they have never been demonstrated in humans. Life extension in people is not an established property of this compound, and any page that implies otherwise is going beyond its sources.
Why telomeres and muscle are not the same subject
This is the point where a body composition site has to be careful, because the slide from one to the other is easy, tempting, and wrong.
Telomere shortening is a consequence of cell division. It is a replicative phenomenon, which is why it dominates discussion of dividing tissues.
Skeletal muscle fibres are not a dividing tissue in that sense. They are large multinucleated cells that do not proliferate the way a fibroblast in a dish does. Muscle loss with age involves fibre size, the number of motor units, protein turnover, nutrition, hormones and, above all, how much load the tissue receives. Those are not the same processes as replicative telomere shortening, and improving a marker in dividing cells does not follow through to them.
So the inference from cellular ageing to muscle ageing is not a small step that nobody has bothered to take. It is a step the biology does not license, and no study in any organism has tested it for this compound: no rodent muscle measurement, no cell work on muscle tissue, no human body composition endpoint.
How this differs from the other Russian peptides in the catalogue
Vendors shelve this beside Semax and Selank, and readers reasonably assume the three sit in the same evidential position. They do not, and the difference is worth holding onto.
Semax is a registered medicine in Russia. It has a regulator, a prescribing practice and clinical use behind it, and the difficulty for a Western reader is access: the evidence exists in a system you cannot audit. That is a transferability problem.
This compound has no approval in Russia or anywhere else. Its difficulty is a different one. The research exists and is published, and a reader can find it, but it comes overwhelmingly from one group, and independent confirmation is limited. That is a replication problem.
The two get flattened into a single sentence, usually something like nothing has been proven in the West, and the flattening loses the useful information. A finding you cannot inspect and a finding nobody else has repeated fail in different ways and would be fixed by different things. The first needs a Western trial. The second needs another laboratory, anywhere, to run the experiment again and publish what happened.
Six things it is not
A growth or repair peptide. Nothing published describes an effect on muscle, tendon or connective tissue in any organism.
An approved medicine. Not in the United States, not in Europe, not anywhere. This distinguishes it sharply from some other Russian developed peptides.
Epithalamin. The pineal extract and the synthetic tetrapeptide are different substances, and evidence about one is not automatically evidence about the other.
A proven longevity drug. Lifespan effects were reported in rodents by one group and have never been shown in humans.
A telomere test result. Activating an enzyme in cultured cells and lengthening telomeres in a living person are separate claims with separate evidence.
A quality controlled product. What ships to a buyer is attested by the seller alone.
Identity claims and their actual footing
| Claim | What stands behind it | Organism | Independently replicated |
|---|---|---|---|
| Synthetic tetrapeptide, Ala-Glu-Asp-Gly | Description of the molecule | Not applicable | Not a research claim |
| Derived from a pineal preparation | Development history | Not applicable | Not a research claim |
| Activates telomerase | Work from one research group | Human cell culture | Limited |
| Extends lifespan | Work from the same group | Mouse, rat | Limited |
| Extends human lifespan | Not demonstrated | None | No |
| Approved somewhere | Nothing | Not applicable | No |
| Increases lean mass | Nothing published | None | Nothing to replicate |
| Slows muscle loss with age | Nothing published | None | Nothing to replicate |
Short answers to the common questions
Is Epithalon the same as Epithalamin?
No. Epithalamin is a pineal preparation and this is a defined synthetic tetrapeptide developed from that work. They should not be treated as interchangeable.
Has it been tested on muscle in any species?
No. Not in mice, not in rats, not in cell culture on muscle tissue, and not in people.
Is it approved anywhere in the world?
No. It has no marketing authorisation in any jurisdiction, and there are no registered Western trials.
Does activating telomerase make someone younger?
That is a much larger claim than the underlying work supports. The reported effects concern an enzyme in cultured cells, not measured ageing in a person.
Why is the research so concentrated in one group?
Because the compound came out of one institute's long programme on pineal peptides. That explains the concentration without removing the problem it creates.
Where an honest description stops
This one is a real molecule with a real research history that a reader can find, attached to claims that go considerably further than the history supports, sold by people with no obligation to tell you which is which.
For anyone reading on a body composition site, the last part of the answer is the operative one. Nothing here has been measured against muscle in any organism, and the mechanism people reach for to bridge the gap is about dividing cells, which muscle fibres largely are not. That is not a cautious reading of thin evidence. It is the absence of any evidence at all on the question this audience is asking.